资源描述：
《调强放射治疗同步替吉奥治疗高龄食管癌患者的疗效观察.doc》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。
1、调强放射治疗同步替吉奥治疗高龄食管癌患者的疗效观察【摘耍】目的：探讨常规分割调强放射治疗同步替吉奥治疗高龄食管癌患者的疗效。方法：选择2011年10月-2013年10月门诊和住院治疗的高龄食管癌患者53例。根据治疗模式不同，分为同步组和对照组，同步组采用调强放射治疗同步替吉奥治疗，对照组采用单纯调强放射治疗。结果：同步组较对照组的副反应略高，但差异无统计学意义（P>0.05）；同步组和对照组患者总有效率分别达到84.00%和57.14%,差异有统计学意义（P=0・033）；同步组和对照组患者12个月随访期内的中位无进展生存期分别为10.84个月和9.36个月，差异有统计学意义（P二0.04
2、4）,同步组和对照组患者的1年生存率分别为88.0%和85.7%,差界无统计学意义（P=0・75）。结论：调强放射治疗同步替吉奥治疗高龄食管癌患者的疗效肯定。【关键词】调强放疗；替吉奥；食管癌中图分类号R735.1文献标识码A文章编号1674-6805（2015）9-0004-03ClinicalAnalysisofElderlyEsophagealCancerPatientsTre且tedwithIntensityModulatedRadiationTherapyandTegafurGimeracilOteracilPotassiumCapsule/WANGWu-long,WANGChu
3、n-lei,YUBai-qing,etal.//ChineseandForeignMedicalResearch,2015,13(9)：4-6[Abstract]Objective：Tostudytheclinicalan且lysisofelderlyesophagealcancerpatientstreatedwithintensitymodulatedradiationtherapy(IMRT)andTegafurGimeracilOteracilPotassiumCapsule.Method：53elderlyesophagealcancerpatientsfromOctober20
4、11toOctober2013wereselected.Accordingtothedifferenttreatmentmodalities,theyweredividedintothesynchronouschemotherapygroupandthecontrolgroup,thesynchronouschemotherapygroupwastreatedwithIMRTandTegafurGimeracilOteracilPotassiumCapsule,thecontrolgroupwastreatedwithIMRT.Result：Thesideeffectsofthesynch
5、ronouschemotherapygroupwashigherthanthatofthecontrolgroup,butthedifferencehadnosignificantdifferencebetweentwogroups(P>0.05)；thetotaleffectiverateofthesynchronouschemotherapygroupwas84.00%,thecontrolgroupwas57.14%,therewasstatisticallysignificantdifference(P二0.033),themedianprogressionfreesurvival
6、ofthesynchronouschemotherapygroupandcontrolgroupwere10.84monthsand9.36months,therewasstatisticallysignificantdifference(P二0.044),thesurvivalrateinoneyearofthesynchronouschemotherapygroupandcontrolgroupwere88.0%and85.7%,therewasnostatisticallysignificantdifference(P二0.75)・Conclusion：Effectivenessof
7、elderlyesophagealcancerpatientstreatedwithTMRTandTegafurGimeraci1OteracilPotassiumCapsuleisdefinite.【Keywords]Intensitymodulatedradiationtherapy；TegafurGimeracilOteracilPotassiumCapsule；EsophagealcancerFirst-auth
